CD5L mRNA expression was quantified in one set of liver biopsy tissues from patients with histologically staged NAFLD, and a set of normal liver tissues collected at the time of resection for benign or secondary cancers. The gene discussed is CD5L; the disease is metabolic dysfunction-associated steatotic liver disease.